{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:14:15Z","timestamp":1781777655930,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.4158\/ep-2018-0465","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T11:15:08Z","timestamp":1547810108000},"page":"427-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Long-Term Outcomes and Prognostic Factors in Patients With Differentiated Thyroid Carcinoma and Bone Metastases"],"prefix":"10.1016","volume":"25","author":[{"given":"Omer","family":"Slook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigal","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Slutzky-Shraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Tsvetov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Robenshtok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Benbassat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2018-0465_bb0010","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer","year":"2009","journal-title":"Thyroid"},{"key":"10.4158\/EP-2018-0465_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1677\/ERC-07-0229","article-title":"Bone metastases from differentiated thyroid carcinoma","volume":"15","author":"Muresan","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.4158\/EP-2018-0465_bb0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM199801293380506","article-title":"Papillary and follicular thyroid carcinoma","volume":"338","author":"Schlumberger","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2018-0465_bb0025","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/jcem.86.4.7407","article-title":"Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer","volume":"86","author":"Mazzaferri","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0465_bb0030","series-title":"Williams textbook of endocrinology","first-page":"457","article-title":"Nontoxic goiter and thyroid neoplasia","author":"Schlumberger","year":"2003"},{"key":"10.4158\/EP-2018-0465_bb0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/01.sla.0000250445.92336.2a","article-title":"Staging systems for papillary thyroid carcinoma: a review and comparison","volume":"245","author":"Lang","year":"2007","journal-title":"Ann Surg"},{"key":"10.4158\/EP-2018-0465_bb0040","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1210\/jcem-63-4-960","article-title":"Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma","volume":"63","author":"Schlumberger","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0465_bb0045","series-title":"Practical management of thyroid cancer","first-page":"171","article-title":"Nonsurgical management of thyroid cancer","author":"Haq","year":"2016"},{"key":"10.4158\/EP-2018-0465_bb0050","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.surg.2009.10.009","article-title":"Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma","volume":"147","author":"Orita","year":"2010","journal-title":"Surgery"},{"key":"10.4158\/EP-2018-0465_bb0055","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/jc.2012-1169","article-title":"Skeletal-related events due to bone metastases from differentiated thyroid cancer","volume":"97","author":"Farooki","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0465_bb0060","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1089\/thy.2013.0633","article-title":"Spinal metastases due to thyroid carcinoma: an analysis of 202 patients","volume":"24","author":"Kushchayeva","year":"2014","journal-title":"Thyroid"},{"key":"10.4158\/EP-2018-0465_bb0065","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.4158\/EP171924.OR","article-title":"Long-term outcomes and prognostic factors in patients with differentiated thyroid cancer and distant metastases","volume":"23","author":"Hirsch","year":"2017","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2018-0465_bb0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/hed.21504","article-title":"Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer","volume":"33","author":"Barney","year":"2011","journal-title":"Head Neck"},{"key":"10.4158\/EP-2018-0465_bb0075","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0465_bb0080","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/cen.12558","article-title":"Lung metastases from differentiated thyroid carcinoma: prognostic factors related to remission and disease-free survival","volume":"82","author":"Chopra","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.4158\/EP-2018-0465_bb0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-15-0296","article-title":"Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors","volume":"173","author":"Song","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2018-0465_bb0090","first-page":"960","article-title":"Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma","volume":"106","author":"Marcocci","year":"1989","journal-title":"Surgery"},{"key":"10.4158\/EP-2018-0465_bb0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/thy.2000.10.261","article-title":"Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients","volume":"10","author":"Pittas","year":"2000","journal-title":"Thyroid"},{"key":"10.4158\/EP-2018-0465_bb0100","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/BF02067343","article-title":"Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?","volume":"16","author":"Proye","year":"1992","journal-title":"World J Surg"},{"key":"10.4158\/EP-2018-0465_bb0105","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jcem.86.4.7390","article-title":"Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas","volume":"86","author":"Bernier","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0465_bb0110","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1089\/thy.1999.9.1227","article-title":"Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases","volume":"9","author":"Lin","year":"1999","journal-title":"Thyroid"},{"key":"10.4158\/EP-2018-0465_bb0115","first-page":"377","article-title":"Papillary and follicular thyroid carcinomas with bone metastases: a series of 39 cases during a period of 18 years","volume":"21","author":"Fanchiang","year":"1998","journal-title":"Changgeng Yi Xue Za Zhi"},{"key":"10.4158\/EP-2018-0465_bb0120","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"World-wide thyroid cancer epidemic? The increasing impact of overdiagnosis","volume":"375","author":"Vaccarella","year":"2016","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2018-0465_bb0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1072-7515(03)00332-6","article-title":"Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma","volume":"197","author":"Shoup","year":"2003","journal-title":"J Am Coll Surg"},{"key":"10.4158\/EP-2018-0465_bb0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/EJE-16-0237","article-title":"Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma","volume":"175","author":"Choi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2018-0465_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/thy.2010.0248","article-title":"Multidisciplinary treatment and survival of patients with vertebral metastases from thyroid carcinoma","volume":"22","author":"Quan","year":"2012","journal-title":"Thyroid"},{"key":"10.4158\/EP-2018-0465_bb0140","first-page":"71","article-title":"The treatment of spinal metastases","volume":"108","author":"Delank","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"10.4158\/EP-2018-0465_bb0145","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/cncr.20756","article-title":"Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy","volume":"103","author":"van der Linden","year":"2005","journal-title":"Cancer"},{"key":"10.4158\/EP-2018-0465_bb0150","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3174\/ajnr.A1137","article-title":"Metastatic spinal lesions: state of the art treatment options and future trends","volume":"29","author":"Georgy","year":"2008","journal-title":"Am J Neuroradiol"},{"key":"10.4158\/EP-2018-0465_bb0155","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1507\/endocrj.52.701","article-title":"Clinical features of bone metastases resulting from thyroid cancer: a review of 28 patients over a 20-year period","volume":"52","author":"Do","year":"2005","journal-title":"Endocr J"},{"key":"10.4158\/EP-2018-0465_bb0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/SLA.0b013e3181b7faf6","article-title":"Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors","volume":"251","author":"Lee","year":"2010","journal-title":"Ann Surg"},{"key":"10.4158\/EP-2018-0465_bb0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1677\/ERC-07-0120","article-title":"Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome","volume":"14","author":"Hindi\u00e9","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.4158\/EP-2018-0465_bb0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12020-013-0123-8","article-title":"Natural history of small radioiodine-avid bone metastases that have no structural correlate on imaging studies","volume":"47","author":"Robenshtok","year":"2014","journal-title":"Endocrine"},{"key":"10.4158\/EP-2018-0465_bb0175","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1245\/s10434-015-4497-0","article-title":"Prospective evaluation of zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma","volume":"22","author":"Orita","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.4158\/EP-2018-0465_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/thy.2010.0169","article-title":"Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma","volume":"21","author":"Orita","year":"2011","journal-title":"Thyroid"},{"key":"10.4158\/EP-2018-0465_bb0185","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1054\/bjoc.2001.1832","article-title":"Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer","volume":"84","author":"Vitale","year":"2001","journal-title":"Br J Cancer"},{"key":"10.4158\/EP-2018-0465_bb0190","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomized, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"},{"key":"10.4158\/EP-2018-0465_bb0195","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S1470-2045(12)70335-2","article-title":"Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomized, double-blind, phase 2 trial","volume":"13","author":"Leboulleux","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.4158\/EP-2018-0465_bb0200","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:06:34Z","timestamp":1761516394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20359036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1530891X20359036"],"URL":"https:\/\/doi.org\/10.4158\/ep-2018-0465","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Outcomes and Prognostic Factors in Patients With Differentiated Thyroid Carcinoma and Bone Metastases","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2018-0465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}